Feasibility and Acceptability of an Electronic Decision Aid for Genetic Testing in Ovarian and Pancreatic Cancer Patients
Authors:
Open Access
- 19 March 2026
- journal article
- Published by Oxford University Press (OUP) in Research Connections
- Vol. 1 (2)
Abstract
Background and Aims: Germline genetic testing is recommended for all patients with ovarian or pancreatic cancer, and alternative service delivery models are needed to meet this demand. We evaluated an electronic decision aid (DA) that can be administered during a visit with an oncology provider. The DA centered around the decision to pursue genetic testing and selection of a specific multi-gene panel. Methods: An electronic DA had previously been developed by a multi-disciplinary team. Patients were enrolled at two academic medical centers. We surveyed participants with ovarian or pancreatic cancer who completed the DA about their experience and knowledge gained. Oncology providers were also surveyed. Results: 92 patients were enrolled. The DA took 13.7 minutes to complete. There was a 20% increase in knowledge scores after using the DA. 95% opted to pursue genetic testing; 20% chose the smallest cancer-specific gene panel, 31% chose the mid-size multi-cancer panel, and 49% chose the largest panel that included limited evidence genes. Nearly all participants (93%) indicated the DA helped their decision-making and 95% would recommend the DA to friends interested in genetic testing. 91% of providers felt patients were well-informed about genetic testing options and 93% indicated the DA did not extend appointment times. Conclusions: Use of a DA for genetic testing is feasible and acceptable. Patients and providers expressed high levels of satisfaction. The wide range of multi-gene panels selected highlights the importance of offering choice. Studies to formally compare the performance of the DA with traditional genetic counseling are warranted.Keywords
This publication has 19 references indexed in Scilit:
- Next-Generation Service Delivery: A Scoping Review of Patient Outcomes Associated with Alternative Models of Genetic Counseling and Genetic Testing for Hereditary CancerCancers, 2018
- The impact of hereditary cancer gene panels on clinical care and lessons learnedCold Spring Harbor Molecular Case Studies, 2017
- Genetic consultation embedded in a gynecologic oncology clinic improves compliance with guideline-based careGynecologic Oncology, 2017
- Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic reviewBMC Public Health, 2017
- Decision aids for people facing health treatment or screening decisionsCochrane Database of Systematic Reviews, 2017
- Multiplex genetic testing: reconsidering utility and informed consent in the era of next-generation sequencingGenetics in Medicine, 2015
- Interactive e‐counselling for genetics pre‐test decisions: where are we now?Clinical Genetics, 2014
- Establishing the effectiveness of patient decision aids: key constructs and measurement instrumentsBMC Medical Informatics and Decision Making, 2013
- Genetic Risk Assessment for Women with Epithelial Ovarian Cancer: Referral Patterns and Outcomes in a University Gynecologic Oncology ClinicJournal of Genetic Counseling, 2013
- A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counselingPsycho-Oncology, 2008